Clinical Efficacy and Safety of Foldable Capsular Vitreous Body Implant Surgery in 22 Cases of Silicone Oil-dependent Eyes

Abstract

Objective

This study aimed to evaluate the clinical efficacy and safety of foldable capsular vitreous body (FCVB) implant surgery in silicone oil-dependent eyes.

Methods

A total of 22 participants with silicone oil-dependent eyes who received treatment with FCVB implant surgery between January 2019 and June 2020 were included in this retrospective study. The intraocular pressure (IOP), best-corrected visual acuity (BCVA), demographic data, and any recorded complications were evaluated.

Results

The postoperative IOP (12.73±4.20 mmHg) was significantly improved (P=0.03) compared to the preoperative IOP (10.23±3.69 mmHg) (the main endpoint). There was no significant difference (P=0.33) in the final BCVA preoperation and 3rd month postoperation (the secondary endpoint). The most common postoperative complication was hyphema. Other common postoperative complications included corneal opacity, a shallow anterior chamber, and a low IOP.

Conclusion

FCVB implant surgery is a safe and effective method for treating silicone oil-dependent eyes; however, attention should be paid to the prevention and timely treatment of complications.

Keywords

foldable capsular vitreous body / silicone oil-dependent eyes

References

[1] IchhpujaniP, JindalA, JayKL. Silicone oil induced glaucoma: a review. Graefes Arch Clin Exp Ophthalmol, 2009, 247: 1585-1593

[2] BorislavD. Cataract after silicone oil implantation. Doc Ophthalmol, 1993, 83: 79-82

[3] LinX, GeJ, GaoQ, et al.. Evaluation of the flexibility, efficacy, and safety of a foldable capsular vitreous body in the treatment of severe retinal detachment. Invest Ophthalmol Vis Sci, 2011, 52: 374-381

[4] GaoQ, MouS, GeJ, et al.. A new strategy to replace the natural vitreous with a novel capsular artificial vitreous body with a pressure-control valve. Eye (Lond), 2008, 22: 461-468

[5] QuiramPA, GonzalesCR, HuW, et al.. Outcomes of vitrectomy with inferior retinectomy in patients with recurrent rhegmatogenous retinal detachments and proliferative vitreoretinopathy. Ophthalmology, 2006, 113(11): 2041-2047

[6] MancinoR, AielloF, CiuffolettiE, et al.. Inferior retinotomy and silicone oil tamponade for recurrent inferior retinal detachment and grade C PVR in eyes previously treated with pars plana vitrectomy or scleral buckle. BMC Ophthalmol, 2015, 15: 173

[7] ZhangXY, TianXM, ZhangBK, et al.. Study on the effectiveness and safety of Foldable Capsular Vitreous Body Implantation. BMC Ophthalmology, 2019, 19: 260

[8] GaoQ, ChenX, GeJ, et al.. Refractive shifts in four selected artificial vitreous substitutes based on Gullstrand-Emsley and Liou Brennan schematic eyes. Invest Ophthalmol Vis Sci, 2009, 50: 3529-3534

[9] LiuY, JiangZ, GaoQ, et al.. Technical standards of foldable capsular vitreous body regarding mechanical, optical and biocom patible properties. Artif Organs, 2010, 34: 836-845

[10] DongFT, DaiRP, JiaY. Clinical features of silicone oil dependent eyes. Zhonghua Yan Ke Za Zhi (Chinese), 2008, 44(11): 998-1001

[11] ChenY, VictoriaR, ZhouLT, et al.. Silicone oil in vitreoretinal surgery: indications, complications, new developments and alternative long-term tamponade agents. Acta Ophthalmol, 2021, 99(3): 240-250

[12] LinX, WangZ, JiangZ, et al.. Preliminary efficacy and safety of a silicone oil-filled foldable capsular vitreous body in the treatment of severe retinal detachment. Retina, 2012, 32(4): 729-741

[13] ZhangX, TianX, ZhangB, et al.. Study on the effectiveness and safety of foldable capsular vitreous body implantation. BMC Ophthalmol, 2019, 19(1): 260-268

[14] LinXF, GeJ, GaoQY, et al.. Evaluation of the flexibility, efficacy, and safety of a fold-able capsular vitreous body in the treatment of severe retinal detachment. Invest Ophthalmol Vis Sci, 2011, 52(1): 374-381

[15] LinXF, SunXY, WangZF, et al.. Three-year efficacy and safety of a silicone oil-filled foldable-capsular-vitreous-body in three cases of severe retinal detachment. Transl Vis Sci Technol, 2016, 5(1): 2

[16] JiaJC, WangXX, XinLQ, et al.. Clinical observation and perception of foldable capsular vitreous body implantation in 73 cases. Guoji Yanke Zazhi (Int Eye Sci), 2020, 20(11): 1975-1978

[17] LiXD, ZhangBK, JiaY, et al.. The clinical effect of foldable capsular vitreous body implantation in the treatment of vitreoretinal disease. Rec Adv Ophthalmol, 2020, 40(7): 670-673